Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Cannabis

WeedMD kicks off 2021 with the development of new Cannabis 2.0 products

WeedMD said its newest Cannabis 2.0 extract products are expected to debut during 2Q 2021, under the company's Color Cannabis and Saturday Cannabis adult-use brands

WeedMD Inc (CVE:WMD) (OTCQX:WDDMF) (FRA:4WE) announced that it is developing new Cannabis 2.0 products as it enters 2021, with extract products featuring live resin, solventless hash, and rosin concentrates.

The company said its newest Cannabis 2.0 extract products are expected to debut during the second quarter of 2021, under WeedMD’s Color Cannabis and Saturday Cannabis adult-use brands.

“WeedMD’s genetic library boasts unique strains, with flavour and aroma profiles widely recognized throughout the industry and we are thrilled to announce we are now expanding into high-value, terpene-rich hash, live resin and rosin products,” WeedMD Interim CEO George Scorsis said in a statement.

READ: WeedMD on a pathway to profitable growth as it accelerates its Cannabis 2.0 efforts

He added: “We are listening to our consumers and retail partners in developing these products and extending our portfolio. Our cultivation, commercial and product teams are now capturing these profiles in a variety of formats, including solventless concentrates and extracts to deliver premium products under our Color and Saturday Cannabis brands.”

“This expanded portfolio is tailor-made for consumers looking for richer cannabis concentrates and alternative cannabis consumption methods.”

WeedMD noted that product development for both solventless cannabis concentrates (including bubble hash and rosin) and hydrocarbon (live resin) extract products is currently underway alongside the company and its third-party processors.

It added that extract products will be produced using WeedMD’s own biomass, grown on-site at the company’s state-of-the-art greenhouse and outdoor field in Strathroy, Ontario.

WeedMD Inc is the parent company of WeedMD RX Inc and Starseed Medicinal Inc, which are federally licensed producers of cannabis products for both the medical and adult-use markets. The company owns a 158-acre greenhouse, outdoor cultivation and processing facility in Strathroy, Ontario.

Contact Sean at sean@proactiveinvestors.com

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK